The Journey to Date in Our Navigation Plan
ISPE's Board of Directors is working to refresh the Strategic Plan.
ISPE's Board of Directors is working to refresh the Strategic Plan.
Welcome to the September-October issue of Pharmaceutical Engineering! This issue features a special preview of the ISPE 2018 Annual Meeting & Expo in Philadelphia, Pennsylvania.
Annual Meeting is a good time to reflect on the work that ISPE is doing to update and improve our structure, delivery of services, and development and implementation of various programs and products. The direction we are following is driven by the ISPE Strategic Plan. Our Strategic Plan, a composite of your collective views and input, guides our decision-making and contains our goals for a four- to five-year horizon.
The current Strategic Plan began in 2016 and concludes next year. ISPE’s Board of Directors is already working to refresh the Strategic Plan. The Strategic Plan’s strategic goals are rapid information delivery, driving efficient manufacturing operations, local and regional relevance, compelling member and industry value, and operational strength.
Great progress has been made in developing and implementing a range of projects to support these goals: we completed 15 projects in 2016 and 20 in 2017. Thirty projects are either complete or in progress for 2018.
Here are just a few of these achievements:
Developing the Strategic Plan and implementing toward its goals is a critical and crucial endeavor that the organization has in defining its remit. It’s a collective responsibility that we all have as one ISPE. Your input in this sense is valued as all ISPE members play an important part in our achievements. Beyond this seminal task, your contributions to Pharmaceutical Engineering, guidance documents, conferences and training, committees, and communities of practice are necessary and appreciated in meeting ISPE’s strategic goals.
I look forward to continuing our work together and I hope to see you in Philadelphia at the 2018 ISPE Annual Meeting & Expo. We will share more about our achievements to date and those that are on the way.
Personalized medicine provides a treatment alternative that utilizes patients’ genetic material to produce therapeutics. According to Market Research Future, the US currently accounts for the largest share of the personalized medicine market, and it is expected to reach US $27.5 million by 2030.
Over time and with effort and determination, women in key leadership positions have proven that these positions are genderless for individuals with the correct set of abilities and knowledge.
ISPE has started 2024 with great momentum, having two technical conferences in the first quarter, the 2024 ISPE Facilities of the Future Conference in San Francisco, California and the 2024 ISPE...